BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9289834)

  • 1. [Conservative treatment of gastroduodenal peptic ulcer perforations: indications and results].
    Alizadeh N; Bühler L; Huber O; Morel P
    Schweiz Med Wochenschr Suppl; 1997; 89():17S-19S. PubMed ID: 9289834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non operative treatment for perforated peptic ulcer: results of a prospective study].
    Songne B; Jean F; Foulatier O; Khalil H; Scotté M
    Ann Chir; 2004 Dec; 129(10):578-82. PubMed ID: 15581818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taylor's method: a therapeutic alternative for perforated gastroduodenal ulcer.
    Dascalescu C; Andriescu L; Bulat C; Danila R; Dodu L; Acornicesei M; Radulescu C
    Hepatogastroenterology; 2006; 53(70):543-6. PubMed ID: 16995458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic strategies in performing emergency surgery for gastroduodenal ulcer perforation in 130 patients over 70 years of age.
    Tsugawa K; Koyanagi N; Hashizume M; Tomikawa M; Akahoshi K; Ayukawa K; Wada H; Tanoue K; Sugimachi K
    Hepatogastroenterology; 2001; 48(37):156-62. PubMed ID: 11268955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple closure and follow up H2 receptor antagonists for perforated peptic ulcer--immediate survival and symptomatic outcome.
    Abbasakoor F; Attwood SE; McGrath JP; Stephens RB
    Ir Med J; 1995; 88(6):207-10. PubMed ID: 8575920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of H2-receptor antagonists on the outcome of treatment of perforated duodenal ulcer.
    Macintyre IM; Millar A
    J R Coll Surg Edinb; 1990 Dec; 35(6):348-52. PubMed ID: 1982317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing patterns in perforated peptic ulcer disease.
    Gunshefski L; Flancbaum L; Brolin RE; Frankel A
    Am Surg; 1990 Apr; 56(4):270-4. PubMed ID: 1973032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal ulcer perforation: have H2 receptor blockers reduced mortality?
    Perakath B; Sitaram V; Khanduri P; Richard J
    Trop Gastroenterol; 1999; 20(1):53-4. PubMed ID: 10464452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of H2 antagonists on outcome of simple closure for perforated duodenal ulcer.
    Koh KB; Chang KW
    Singapore Med J; 1992 Oct; 33(5):472-3. PubMed ID: 1360708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency gastric ulcer complications in elderly. Factors affecting the morbidity and mortality in relation to therapeutic approaches.
    Di Carlo I; Toro A; Sparatore F; Primo S; Barbagallo F; Di Blasi M
    Minerva Chir; 2006 Aug; 61(4):325-32. PubMed ID: 17122765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perforated gastroduodenal ulcer. I. postoperative mortality and late results following simple suturing].
    Krenzien J; Röding H; Rudtke B
    Zentralbl Chir; 1990; 115(8):457-69. PubMed ID: 2193471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti H2 receptors and perforated peptic ulcer. Review of 442 cases].
    Mastroianni V; Calgaro M; Manfredi S; Manzini R; Bevilacqua S
    Minerva Chir; 1989 Nov; 44(21):2259-62. PubMed ID: 2576300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term evaluation of the treatment of perforated gastroduodenal ulcer using a median suture].
    Uccheddu A; Murgia C; Dazzi C; Licheri S; Pia G; Cagetti M
    Minerva Chir; 1989 Jun; 44(12):1637-41. PubMed ID: 2570383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is it possible to expand the indications for primary radical operations for perforated gastric and duodenal ulcer?].
    Vachev AN; Adyshirin-Zade EE; Frolova EV; Dergal' SV; Kozlov AA
    Eksp Klin Gastroenterol; 2010; (2):43-7. PubMed ID: 20496809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological behavior of perforated peptic ulcer before and after the introduction of the antisecretory drug therapy. Our experience].
    Sacco R; Giovanelli A; Giuliano L; Piazzalunga D; Poletti EM; Arrigoni F; Cassinelli GB
    Minerva Chir; 1995 Oct; 50(10):871-8. PubMed ID: 8684634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of surgery in the therapy of peptic ulcer after arrival of H2-blocking drugs].
    Perri S; Amendolara M; Breda E; Todarello V; Gallo G; Pietrangeli F; Meneghini G; Gelmi GF
    G Chir; 1990 Sep; 11(9):466-70. PubMed ID: 1981139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perforation of gastroduodenal ulcer: a risk analysis].
    Walgenbach S; Bernhard G; Dürr HR; Weis C
    Med Klin (Munich); 1992 Aug; 87(8):403-7. PubMed ID: 1406471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perioperative mortality for perforated duodenal and gastric ulcer--analysis of 226 patients].
    Barczyński M; Reś F; Cichoń S; Barczyński M
    Przegl Lek; 1999; 56(3):192-7. PubMed ID: 10442007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perforated peptic ulcer--a 12-year material].
    Forsmo HM; Glomsaker T; Vandvik PO
    Tidsskr Nor Laegeforen; 2005 Jun; 125(13):1822-4. PubMed ID: 16012551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of nonoperative treatment for perforated peptic ulcer.
    Crofts TJ; Park KG; Steele RJ; Chung SS; Li AK
    N Engl J Med; 1989 Apr; 320(15):970-3. PubMed ID: 2927479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.